Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
Clinical trial NCT00267085 · COMPLETED
Trial details
- NCT number
- NCT00267085
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.